BIOCQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BIOCQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-27), Biocept's current share price is $0.0001. Biocept's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2023 was $2,630.16. Biocept's Cyclically Adjusted PB Ratio for today is 0.00.
The historical rank and industry rank for Biocept's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Biocept's highest Cyclically Adjusted PB Ratio was 0.04. The lowest was 0.01. And the median was 0.01.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Biocept's adjusted book value per share data for the three months ended in Jun. 2023 was $0.120. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2,630.16 for the trailing ten years ended in Jun. 2023.
The historical data trend for Biocept's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biocept Quarterly Data | ||||||||||||||||||||
Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 0.01 | 0.01 | 0.01 | - | - |
For the Diagnostics & Research subindustry, Biocept's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Biocept's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Biocept's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Biocept's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 0.0001 | / | 2630.16 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biocept's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2023 is calculated as:
For example, Biocept's adjusted Book Value per Share data for the three months ended in Jun. 2023 was:
Adj_Book | = | Book Value per Share | / | CPI of Jun. 2023 (Change) | * | Current CPI (Jun. 2023) |
= | 0.12 | / | 128.7287 | * | 128.7287 | |
= | 0.120 |
Current CPI (Jun. 2023) = 128.7287.
Biocept Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201309 | -20,658.824 | 98.790 | -26,919.562 |
201312 | -73,311.765 | 98.326 | -95,980.085 |
201403 | 58,481.250 | 99.695 | 75,512.845 |
201406 | 43,018.750 | 100.560 | 55,069.365 |
201409 | 20,906.250 | 100.428 | 26,797.703 |
201412 | -1,381.250 | 99.070 | -1,794.762 |
201503 | 20,580.303 | 99.621 | 26,593.519 |
201506 | 16,014.493 | 100.684 | 20,475.219 |
201509 | 9,897.143 | 100.392 | 12,690.779 |
201512 | 5,058.904 | 99.792 | 6,525.809 |
201603 | -660.811 | 100.470 | -846.671 |
201606 | -455.435 | 101.688 | -576.543 |
201609 | -4,898.925 | 101.861 | -6,191.106 |
201612 | 339.691 | 101.863 | 429.284 |
201703 | 3,519.595 | 102.862 | 4,404.659 |
201706 | 2,301.567 | 103.349 | 2,866.766 |
201709 | 1,198.214 | 104.136 | 1,481.189 |
201712 | 331.458 | 104.011 | 410.227 |
201803 | 1,125.397 | 105.290 | 1,375.929 |
201806 | 332.194 | 106.317 | 402.221 |
201809 | 681.250 | 106.507 | 823.389 |
201812 | 197.213 | 105.998 | 239.504 |
201903 | 222.834 | 107.251 | 267.459 |
201906 | 170.729 | 108.070 | 203.367 |
201909 | 100.417 | 108.329 | 119.326 |
201912 | 61.389 | 108.420 | 72.888 |
202003 | 62.728 | 108.902 | 74.149 |
202006 | 59.639 | 108.767 | 70.584 |
202009 | 47.818 | 109.815 | 56.054 |
202012 | 53.053 | 109.897 | 62.144 |
202103 | 59.924 | 111.754 | 69.026 |
202106 | 61.532 | 114.631 | 69.099 |
202109 | 72.091 | 115.734 | 80.185 |
202112 | 66.731 | 117.630 | 73.028 |
202203 | 65.927 | 121.301 | 69.964 |
202206 | 57.536 | 125.017 | 59.244 |
202209 | 48.394 | 125.227 | 49.747 |
202212 | 15.571 | 125.222 | 16.007 |
202303 | 4.095 | 127.348 | 4.139 |
202306 | 0.120 | 128.729 | 0.120 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Biocept's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert Walsh | officer: VP, Controller | 9955 MESA RIM ROAD, SAN DIEGO CA 92121 |
Quyen Thi Dao-haddock | director | C/O: PRESIDIO PROPERTY TRUST, INC., 1282 PACIFIC OAKS PLACE, ESCONDIDO CA 92029 |
Philippe Marchand | officer: Chief Operations Officer | C/O BIOCEPT, INC., 9955 MESA RIM ROAD, SAN DIEGO CA 92121 |
Darrell Taylor | officer: Sr. V.P., General Counsel | C/O BIOCEPT, INC., 9955 MESA RIM ROAD, SAN DIEGO CA 92121 |
David F Hale | director, officer: EXECUTIVE CHAIRMAN | 1042-B NORTH EL CAMINO REAL, SUITE 430, ENCINITAS CA 92024 |
Antonino Morales | director | C/O BICOCEPT, INC., 9955 MESA RIM ROAD, SAN DIEGO CA 92121 |
Linda M Rubinstein | director | 25861 INDUSTRIAL BLVD, HAYWARD CA 94545 |
Samuel D Riccitelli | director | 2850 FRONTIER DR., WARSAW IN 46582 |
Michael C Dugan | officer: Chief Med Off & Med. Director | 2211 MICHIGAN AVE, SANTA MONICA CA 90404-3900 |
Dunn Cory | officer: Sr. VP Corp. Development | C/O BIOCEPT, INC., 5810 NANCY RIDGE DR., # 150, SAN DIEGO CA 92121 |
Edwin Hendrick | officer: SVP, Chief Commercial Officer | 2010 MAIN STREET, SUITE 600, IRVINE CA 92614 |
Michael J Terry | officer: Sr VP Comm. Operations | |
Marsha Alpert Chandler | director | 7863 ENTRADA ANGELICA, SAN DIEGO CA 92127 |
Michael W. Nall | director, officer: CEO AND PRESIDENT | 4 WOODHAVEN DRIVE, LAGUNA NIGUEL CA 92677 |
Timothy Kennedy | officer: CFO, Sr V.P. Operations & Sec. | 5810 NANCY RIDGE DRIVE, SUITE 150, SAN DIEGO CA 92121 |
From GuruFocus
By Business Wire Business Wire • 06-07-2022
By Business Wire • 08-14-2023
By Business Wire Business Wire • 08-31-2022
By Business Wire • 09-05-2023
By Business Wire Business Wire • 06-05-2023
By Business Wire Business Wire • 04-08-2022
By Business Wire Business Wire • 10-19-2022
By Business Wire Business Wire • 01-06-2023
By Business Wire • 07-13-2023
By Business Wire Business Wire • 04-06-2022